Literature DB >> 29214388

Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them?

Melina Dritsaki1, Alastair Gray2, Stavros Petrou3, Susan Dutton4, Sarah E Lamb4, Joanna C Thorn5.   

Abstract

Mesh：

Year:  2018        PMID： 29214388     DOI： 10.1007/s40273-017-0598-x

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

Review 1.  Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches.

Authors:  Dyfrig Hughes; Joanna Charles; Dalia Dawoud; Rhiannon Tudor Edwards; Emily Holmes; Carys Jones; Paul Parham; Catrin Plumpton; Colin Ridyard; Huw Lloyd-Williams; Eifiona Wood; Seow Tien Yeo
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981

Review 2.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Authors:  Scott Ramsey; Richard Willke; Andrew Briggs; Ruth Brown; Martin Buxton; Anita Chawla; John Cook; Henry Glick; Bengt Liljas; Diana Petitti; Shelby Reed
Journal:  Value Health       Date:  2005 Sep-Oct       Impact factor: 5.725

3.  Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting.

Authors:  Stavros Petrou; Alastair Gray
Journal:  BMJ       Date:  2011-04-07

4.  Economic evaluation alongside pragmatic randomised trials: developing a standard operating procedure for clinical trials units.

Authors:  Rhiannon T Edwards; Barry Hounsome; Pat Linck; Ian T Russell
Journal:  Trials       Date:  2008-11-17       Impact factor: 2.279
  4 in total
  4 in total

1.  The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.

Authors:  Serigne N Lo; Amelia K Smit; David Espinoza; Anne E Cust
Journal:  Trials       Date:  2020-06-30       Impact factor: 2.279

2.  Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD).

Authors:  May Ee Png; Melina Dritsaki; Alastair Gray; Rafael Pinedo-Villanueva; Oliver Rivero-Arias; Jagdeep Nanchahal
Journal:  Wellcome Open Res       Date:  2019-02-12

3.  Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis.

Authors:  Baptiste Leurent; Manuel Gomes; Suzie Cro; Nicola Wiles; James R Carpenter
Journal:  Health Econ       Date:  2019-12-17       Impact factor: 3.046

4.  Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis.

Authors:  Ferrán Catalá-López; Lisa Caulley; Manuel Ridao; Brian Hutton; Don Husereau; Michael F Drummond; Adolfo Alonso-Arroyo; Manuel Pardo-Fernández; Enrique Bernal-Delgado; Ricard Meneu; Rafael Tabarés-Seisdedos; José Ramón Repullo; David Moher
Journal:  BMJ Open       Date:  2020-02-13       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.